As of 2024-12-12, the Intrinsic Value of Impel Neuropharma Inc (IMPL) is
-115.47 USD. This IMPL valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.24 USD, the upside of Impel Neuropharma Inc is
-47,992.16%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-115.47 USD
Intrinsic Value
IMPL Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-115.47 - -115.47 |
-115.47 |
-47,992.16% |
| P/E |
(448.48) - (465.11) |
(441.09) |
-183048.4% |
| DDM - Stable |
(13.28) - (24.94) |
(19.11) |
-8025.1% |
| DDM - Multi |
(3.59) - (5.54) |
(4.37) |
-1911.2% |
IMPL Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.96 |
| Beta |
3.54 |
| Outstanding shares (mil) |
3.97 |
| Enterprise Value (mil) |
-14.24 |
| Market risk premium |
5.00% |
| Cost of Equity |
106.54% |
| Cost of Debt |
5.00% |
| WACC |
5.68% |